Compound management beyond efficiency

Journal of Biomolecular Screening

Volumn 14, Issue 5, 2009, Pages 485-491

  Burr, Ian ^a   Winchester, Toby ^a   Keighley, Wilma ^a   Sewing, Andreas ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Compound management; Lead optimization; Material management; Research

Indexed keywords

COMPOUND MANAGEMENT; COST BENEFIT ANALYSIS; DRUG MANUFACTURE; DRUG STORAGE; HIGH THROUGHPUT SCREENING; JOB SATISFACTION; MATERIALS MANAGEMENT; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

DRUG DISCOVERY; DRUG INDUSTRY; EFFICIENCY, ORGANIZATIONAL; HUMANS; MODELS, ORGANIZATIONAL;

EID: 67449096968     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057109333978     Document Type: Review

References (15)

1. Schopfer U., Andreae MRM, Hueber M., Saur A., Kummer MO, Girod M., et al. Compound hub: efficiency gains through innovative sample management processes. Comb Chem High Throughput Screen 2007 ; 10: 283-287. (Pubitemid 46709475)
2. Yasgur A., Shinn P., Jadhav A., Auld D., Michael S., Zheng W., et al. Compound management for quantitative high-throughput screening. JALA 2008 ; 13: 79-89. (Pubitemid 351325745)
3. Kozikowski BA, Burt TM, Tirey DA, Williams LE, Kuzmak BR, Stanton DT, et al. The effect of freeze/thaw cycles on the stability of compounds in DMSO. J Biomol Screen 2003 ; 8: 210-214.
4. Cheng X., Hochlowsky J., Hepp D., Beckner C., Kantor S., Schmitt R.: Studies on repository compound stability in DMSO under various conditions. J Biomol Screen 2003 ; 8: 292-304.
5. Bowes S., Sun D., Kaffashan A., Zeng C., Chuaqui C., Hronowski X., et al. Quality assessment and analysis of Biogen idec compound library. J Biomol Screen 2006 ; 11: 828-834.
6. Di L., Kerns EH: Biological assay challenges from compound solubility: strategies for bioassay optimisation. Drug Discov Today 2006 ; 11: 446-451.
7. Squibb AW, Taylor RM, Parnas BL, Williams G., Girdler R., Waghorn P., et al. Application of parallel gradient high performance liquid chromatography with ultra-violet, evaporative light scattering and electrospray mass spectrometric detection for the quantitative quality control of the compound file to support pharmaceutical discovery. J Chrom A 2008 ; 1189: 101-108.
8. Oakland JS: Total Quality Management: The Route to Improving Performance. 2 nd ed. Oxford, UK: Butterworth-Heinemann Ltd, 1993.
9. Lipinski CA: Profiling in drug discovery for lead selection. in Borchardt RT, Kerns EH, Lipinski CA, Thakker DR, Wang B (eds): Biotechnology: Pharmaceutical Aspects. Vol. 1. Arlington, VA: AAPS Press, 2004: 93-125.
10. Gribbon O., Lyons R., Laflin P., Bradley J., Chambers C., Williams BS, et al. Evaluating real life HTS data. J Biomol Screen 2005 ; 10: 99-107.
11. Meerpoel L., Schroven M., Goris K., Demoen K., Marsden S.: Outsourcing to exploit a key asset. Drug Discov Today 2006 ; 11: 556-560. (Pubitemid 44269345)
12. Bender A., Bojanic D., Davies JW, Crisman TJ, Mikhailov D., Schreiber J., et al. Which aspects of HTS are empirically correlated with downstream success? Curr Opin Drug Discov Devel 2008 ; 11: 327-337. (Pubitemid 351572442)
13. Clark DE: Outsourcing lead optimisation: constant change is here to stay. Drug Discov Today 2007 ; 12: 62-70. (Pubitemid 46014483)
14. Kang L., Chung BG, Langer R., Khademhosseini A.: Microfluidics for drug discovery and development: from target selection to product life-cycle management. Drug Discov Today 2008 ; 13: 1-13.
15. Choi CJ, Cunningham BT: A 96-well microplate incorporating a replica molded microfluidic network integrated with photonic crystal biosensors for high throughput kinetic biomolecular interaction analysis. LabChip 2007 ; 7: 550-556. (Pubitemid 46699211)